These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38049202)

  • 1. Severe communication delays are independent of seizure burden and persist despite contemporary treatments in SCN1A+ Dravet syndrome: Insights from the ENVISION natural history study.
    Perry MS; Scheffer IE; Sullivan J; Brunklaus A; Boronat S; Wheless JW; Laux L; Patel AD; Roberts CM; Dlugos D; Holder D; Knupp KG; Lallas M; Phillips S; Segal E; Smeyers P; Lal D; Wirrell E; Zuberi S; Brünger T; Wojnaroski M; Maru B; O'Donnell P; Morton M; James E; Vila MC; Huang N; Gofshteyn JS; Rico S
    Epilepsia; 2024 Feb; 65(2):322-337. PubMed ID: 38049202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
    Li W; Schneider AL; Scheffer IE
    Epilepsia; 2021 Sep; 62(9):2205-2217. PubMed ID: 34338318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsia; 2018 Jun; 59(6):1154-1165. PubMed ID: 29750338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: a population-based ten-year cohort study.
    Verbeek NE; van der Maas NA; Jansen FE; van Kempen MJ; Lindhout D; Brilstra EH
    PLoS One; 2013; 8(6):e65758. PubMed ID: 23762420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome.
    Bishop KI; Isquith PK; Gioia GA; Gammaitoni AR; Farfel G; Galer BS; Nabbout R; Wirrell EC; Polster T; Sullivan J
    Epilepsy Behav; 2021 Aug; 121(Pt A):108024. PubMed ID: 34023810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and clinical correlation of Dravet syndrome and its mimics - experience of a tertiary center in Taiwan.
    Liu YH; Cheng YT; Tsai MH; Chou IJ; Hung PC; Hsieh MY; Wang YS; Chen YJ; Kuo CY; Lin JJ; Wang HS; Lin KL
    Pediatr Neonatol; 2021 Sep; 62(5):550-558. PubMed ID: 34226156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication.
    Matricardi S; Cestèle S; Trivisano M; Kassabian B; Leroudier N; Vittorini R; Nosadini M; Cesaroni E; Siliquini S; Marinaccio C; Longaretti F; Podestà B; Operto FF; Luisi C; Sartori S; Boniver C; Specchio N; Vigevano F; Marini C; Mantegazza M
    Epilepsia; 2023 May; 64(5):1331-1347. PubMed ID: 36636894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy.
    Nabbout R; Chemaly N; Chipaux M; Barcia G; Bouis C; Dubouch C; Leunen D; Jambaqué I; Dulac O; Dellatolas G; Chiron C
    Orphanet J Rare Dis; 2013 Nov; 8():176. PubMed ID: 24225340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When is a child with status epilepticus likely to have Dravet syndrome?
    Le Gal F; Lebon S; Ramelli GP; Datta AN; Mercati D; Maier O; Combescure C; Rodriguez MI; Seeck M; Roulet E; Korff CM
    Epilepsy Res; 2014 May; 108(4):740-7. PubMed ID: 24679980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dravet syndrome in children-A population-based study.
    Bjurulf B; Reilly C; Sigurdsson GV; Thunström S; Kolbjer S; Hallböök T
    Epilepsy Res; 2022 May; 182():106922. PubMed ID: 35461153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convulsive seizures and some behavioral comorbidities are uncoupled in the Scn1a
    Fadila S; Quinn S; Turchetti Maia A; Yakubovich D; Ovadia M; Anderson KL; Giladi M; Rubinstein M
    Epilepsia; 2020 Oct; 61(10):2289-2300. PubMed ID: 32865826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dravet syndrome: seizure control and gait in adults with different SCN1A mutations.
    Rilstone JJ; Coelho FM; Minassian BA; Andrade DM
    Epilepsia; 2012 Aug; 53(8):1421-8. PubMed ID: 22780858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoclonic Absence Seizures in Dravet Syndrome.
    Myers KA; Scheffer IE
    Pediatr Neurol; 2017 May; 70():67-69. PubMed ID: 28233668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
    Brunklaus A; Brünger T; Feng T; Fons C; Lehikoinen A; Panagiotakaki E; Vintan MA; Symonds J; Andrew J; Arzimanoglou A; Delima S; Gallois J; Hanrahan D; Lesca G; MacLeod S; Marjanovic D; McTague A; Nuñez-Enamorado N; Perez-Palma E; Scott Perry M; Pysden K; Russ-Hall SJ; Scheffer IE; Sully K; Syrbe S; Vaher U; Velayutham M; Vogt J; Weiss S; Wirrell E; Zuberi SM; Lal D; Møller RS; Mantegazza M; Cestèle S
    Brain; 2022 Nov; 145(11):3816-3831. PubMed ID: 35696452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination and occurrence of seizures in SCN1A mutation-positive patients: a multicenter Italian study.
    Zamponi N; Passamonti C; Petrelli C; Veggiotti P; Baldassari C; Verrotti A; Capovilla G; Viri M; Coppola G; Vignoli A
    Pediatr Neurol; 2014 Mar; 50(3):228-32. PubMed ID: 24405698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features and SCN1A gene mutation analysis of severe myoclonic epilepsy of infancy].
    Zhang YH; Sun HH; Liu XY; Ma XW; Yang ZX; Xiong H; Qin J; Lin Q; Wu XR
    Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):769-73. PubMed ID: 19099883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
    Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW
    Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of SCN1A missense and truncation variants in a large Japanese cohort with Dravet syndrome.
    Ishii A; Watkins JC; Chen D; Hirose S; Hammer MF
    Epilepsia; 2017 Feb; 58(2):282-290. PubMed ID: 28012175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice.
    Hawkins NA; Jurado M; Thaxton TT; Duarte SE; Barse L; Tatsukawa T; Yamakawa K; Nishi T; Kondo S; Miyamoto M; Abrahams BS; During MJ; Kearney JA
    Epilepsia; 2021 Nov; 62(11):2845-2857. PubMed ID: 34510432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.